Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

Obstetrician/gynecologists can diagnose and manage female hair loss with careful history taking and examination.

Low iron levels are a significant risk factor for hair loss, while high vitamin D levels might be a response to hair loss, not a cause.

Most HIV patients in the study showed skin and mucous membrane issues, with oral thrush being the most common.

Hair ages and thins due to factors like inflammation and stress, and treatments like antioxidants and hormones might improve hair health.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

COVID-19 can cause hair loss starting as early as 18 days after infection.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Higher levels of ischemia-modified albumin in telogen effluvium patients may indicate oxidative stress.

Some medications, including retinoids, antifungals, and psychotropic drugs, can cause reversible hair loss if stopped or doses are reduced.

Women's hair loss can be due to hormonal changes and various conditions, with treatments focusing on stopping progression and managing symptoms.

Telogen effluvium is a condition that causes temporary hair loss.

Indian dermatologists recommend treating common hair loss with a balanced diet, stress reduction, mild shampoos, and sometimes minoxidil and supplements.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Weight loss can cause temporary hair loss, especially in women and older adults.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

The conclusion is that treatments for Telogen Effluvium exist, but standard treatment guidelines are needed.

COVID-19 patients often experience hair loss and scalp pain, which may be related to the severity of their infection and treatment drugs.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

New understanding and treatments for hair loss are improving, but more research is needed.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Natural products and phytochemicals may help with hair regrowth, but more research is needed.

Hair follicles are essential for skin health, aiding in hair growth, wound healing, and immune function.